Abstract
Purpose
Regev et al. first re-introduced the method of atraumatic tooth extraction with orthodontic elastics in 2008. Since then, the method has been mentioned regularly in literature. Nevertheless, the need for additional more detailed information remains.
Methods
We present a review of literature and a retrospective analysis of our three patients receiving bisphosphonate medication. Two of our patients suffered from bisphosphonate-related osteonecrosis of the jaw (BRONJ). All three patients underwent atraumatic tooth extraction, which we describe in detail.
Results
Regev et al. reported satisfactory results using the novel method. We removed six teeth in two patients with continued chemotherapy or bisphosphonate therapy in a time span of 26.2 ± 16.4 weeks successfully. None of the patients developed exposed bone in the follow-up (7.4 ± 0.2 months). In one case, the technique had to be discontinued due to increasing tooth soreness.
Conclusions
Atraumatic tooth extraction seems to be a safe method to prevent bone exposure, even in cases with BRONJ. The time required of our patients for exfoliation exceeded the time mentioned in literature considerably. This proved to be a major limitation. Our cases showed that patients with good compliance, no sore teeth, or painful BRONJ lesions, benefited from atraumatic tooth extraction. One of the method’s major advantages might be the possibility to continue chemotherapy and bisphosphonate therapy throughout the treatment.
Similar content being viewed by others
References
Marx RE (2003) Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 61:1115–1117
Crass MF (1941) A history of the match industry. J Chem Educ 18:428–432
Sarin J, DeRossi SS, Akintoye SO (2008) Updates on bisphosphonates and potential pathobiology of bisphosphonate-induced jaw osteonecrosis. Oral Dis 14:277–285
Ruggiero SL, Dodson TB, Assael LA, Landesberg R, Marx RE, Mehrotra B (2009) American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws—2009 update. J Oral Maxillofac Surg 67:2–12
Allen MR, Burr DB (2009) The pathogenesis of bisphosphonate-related osteonecrosis of the jaw: so many hypotheses, so few data. J Oral Maxillofac Surg 67(Suppl):61–70
Reid IR, Bolland MJ, Grey AB (2007) Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity? Bone 41:318–320
Brozoski MA, Traina AA, Zindel Deboni MC, Martins Marques M, Naclerio-Homem Mda, G (2012) Bisphosphonate-related osteonecrosis of the jaw. Rev Bras Reumatol 52:265–270
Walter C, Al-Nawas B, Frickhofen N, Gamm H, Beck J, Reinsch L et al (2010) Prevalence of bisphosphonate associated osteonecrosis of the jaws in multiple myeloma patients. Head Face Med 6:11–19
Yoneda T, Hagino H, Sugimoto T, Ohta H, Takahashi S, Soen S et al (2010) Bisphosphonate-related osteonecrosis of the jaw: position paper from the Allied Task Force Committee of Japanese Society, Japanese Society of Periodontology, Japanese Society for Oral and Maxillofacial Radiology, and Japanese Society of Oral and Maxillofacial Surgeons. J Bone Miner Metab 28:365–385
Lam DK, Sandor GK, Holmes HI, Evans AW, Clokie CM (2007) A review of bisphosphonate-associated osteonecrosis of the jaws and its management. J Can Dent Assoc 73:417–422
Miksad RA, Lai KC, Dodson TB, Woo SB, Treister NS, Akinyemi O et al (2011) Quality of life implications of bisphosphonate-associated osteonecrosis of the jaw. Oncologist 16:121–132
Bagan JV, Jmenez Y, Murillo J, Hernandez S, Poveda R, Sanchis JM et al (2006) Jaw osteonecrosis associated with bisphosphonates: multiple exposed areas and its relationship to teeth extractions: study of 20 cases. Oral Oncol 42:327–329
Vescovi P, Campisi G, Fusco V, Mergoni G, Manfredi M, Merigo E et al (2011) Surgery-triggered and non surgery-triggered bisphosphonate-related osteonecrosis of the jaws (BRONJ): a retrospective analysis of 567 cases in an Italian multicenter study. Oral Oncol 47:191–194
Badros A, Weikel D, Salama A, Goloubeva O, Schneider A, Rapoport A et al (2006) Osteonecrosis of the jaw in multiple myeloma patients. Clinical features and risk factors. J Clin Oncol 24:945–952
Borromeo GL, Tsao CE, Darby IB, Eberling PR (2011) A review of clinical implications of bisphosphonates in dentistry. Aust Dent J 56:2–9
Otto S, Schreyer C, Hafner S, Mast G, Ehrenfeld M, Stürzenbaum S et al (2012) Bisphosphonate-related osteonecrosis of the jaws—characteristics, risk factors, clinical features, localisation and impact on oncological treatment. J Craniomaxillofac Surg 40:303–309
Borromeo GL, Brand C, Clement JG, McCullough M, Thomson W, Flitzanis E et al (2011) Is bisphosphonate therapy for benign bone disease associated with impaired dental healing? A case controlled study. BMC Musculoskelet Disord 12:71–81
Urade M, Tanaka N, Furusawa K, Shimada J, Shibata T, Kirita T et al (2011) Nationwide survey for bisphosphonate-related osteonecrosis of the jaw in Japan. J Oral Maxillofac Surg 69:e364–e371
Boonyapakorn T, Schirmer I, Reichart PA, Sturm I, Massenkeil G (2008) Bisphosphonate-induced osteonecrosis of the jaws: prospective study of 80 patients with multiple myeloma and other malignancies. Oral Oncol 44:857–869
Mavrokokki T, Cheng A, Stein B, Goss A (2007) Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia. J Oral Maxillofac Surg 65:415–423
Allen MR, Kubek DJ, Burr DB, Ruggiero SL, Chu TM (2011) Compromised osseous healing of dental extraction sites in zoledronic acid-treated dogs. Osteoporos Int 22:693–702
Hoefert S, Eufinger H (2010) Sunitinib may raise the risk of bisphosphonate-related osteonecrosis of the jaw: presentation of three cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 10:463–469
Ferlito S, Puzzo S, Liardo C (2011) Preventive protocol for tooth extractions in patients treated with zoledronate: a case series. J Oral Maxillofac Surg 69:e1–e4
Regev E, Lustmann J, Nashef R (2008) Atraumatic teeth extraction in bisphosphonate-treated patients. J Oral Maxillofac Surg 66:1157–1161
Lodi G, Sardella A, Salis A, Demarosi F, Tarozzi M, Carrassi A (2010) Tooth extraction in patients taking intravenous bisphosphonates: a preventive protocol and case series. J Oral Maxillofac Surg 68:107–110
Kyrgidis A, Vahtsevanos K, Koloutsos G, Andreadis C, Boukovinas I, Teleioudis Z et al (2008) Bisphosphonate related osteonecrosis of the jaws: risk factors in breast cancer patients. A case control study. J Clin Oncol 26:4634–4638
Sonis ST, Watkins BA, Lyng GD, Lerman MA, Anderson KC (2009) Bony changes in the jaws of the rat treated with zoledronic acid and dexamethasone before dental extraction mimic bisphosphonate-related osteonecrosis in cancer patients. Oral Oncol 45:164–172
Kobayashi Y, Hiraga T, Ueda A, Wang L, Matsumoto-Nakano M, Hata K et al (2010) Zoledronic acid delays wound healing of the tooth extraction socket, inhibits oral epithelial cell migration, and promotes proliferation and adhesion to hydroxyapatite of the oral bacteria without causing osteonecrosis of the jaw, in mice. J Bone Miner Metab 28:165–175
Saia G, Blandamura S, Bettini G, Tronchet A, Totola A, Bedogni G (2010) Occurrence of bisphosphonate-related osteonecrosis of the jaw after surgical tooth extraction. J Oral Maxillofac Surg 68:797–804
Kim RH, Lee RS, Williams D, Bae S, Woo J, Lieberman M (2011) Bisphosphonates induce senescence in normal human oral keratinocytes. J Dent Res 90:810–816
Ravosa MJ, Ning J, Liu Y, Stack S (2011) Bisphosphonate effects on the behaviour of oral epithelial cells and oral fibroblasts. Arch Oral Biol 56:491–498
Cozin M, Pinker BM, Solemani K, Zuniga JM, Dadaian SC, Cremers S et al (2011) Novel therapy to reverse the cellular effects of bisphosphonates on primary human oral fibroblasts. J Oral Maxillofac Surg 69:2564–2578
Rodriguez-Caballero A, Torres-Lagares D, Robles-Garcia M, Pachon-Ilanez J, Gonzalez-Padilla D, Gutierrez-Perez JL (2012) Cancer treatment-induced oral mucositis: a critical review. Int J Oral Maxillofac Surg 41:225–238
Cheng KK, Lee V, Li CH, Yuen LY, Epstein JB (2012) Oral mucositis in pediatric and adolescent patients undergoing chemotherapy: the impact of symptoms on quality of life. Support Care Cancer 20:2335–2342
Epstein JB, Klasser GD (2006) Emerging approaches for prophylaxis and management of oropharyngeal mucositis in cancer therapy. Expert Opin Emerg Drugs 11:353–373
Nishimura N, Nakano K, Ueda K, Kodaira M, Yamada S, Mishima Y et al (2012) Prospective evaluation of incidence and severity of oral mucositis induced by conventional chemotherapy in solid tumors and malignant lymphomas. Support Care Cancer 20:2053–2059
Gutzmer R, Wollenberg A, Ugurel S, Homey B, Ganser A, Kapp A (2012) Cutaneous side effects of new antitumor drugs: clinical features and management. Dtsch Arztebl Int 109:133–140
Estilo CL, Fornier M, Farooki A, Carlson D, Bohle G, Huryn JM (2008) Osteonecrosis of the jaw related to bevacizumab. J Clin Oncol 26:4037–4038
Suwattee P, Chow S, Berg BC, Warshaw EM (2008) Sunitinib: a cause of bullous palmoplantar erythrodysethesia, periungual erythema, and mucositis. Arch Dermatol 144:123–125
Brunello A, Saia G, Bedogni A, Basso U (2009) Worsening of osteonecrosis of the jaw during treatment with sunitinib in a patient with metastatic renal cell carcinoma. Bone 44:173–175
Aghaloo TL, Kang B, Sung EC, Shoff M, Ronconi M, Gotcher JE et al (2011) Periodontal disease and bisphosphonates induce osteonecrosis of the jaws in the rat. J Bone Mineral Res 26:1871–1882
Marx RE, Sawatari Y, Fortin M, Broumand V (2005) Bisphosphonate-induced exposed bone (osteonecrosis/osteoporosis) of the jaws: risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 63:1567–1575
Kushiyama M, Shimazaki Y, Murakami M, Yamashita Y (2009) Relationship between intake of green tea and periodontal disease. J Periodontol 80:372–377
Jeffcoat MK, Cizza G, Shih WJ, Genco R, Lombardi A (2007) Efficacy of bisphosphonates for the control of alveolar bone loss in periodontitis. J Int Acad Periodontol 9:70–76
Acknowledgments
We would like to thank Marlin Schmidt, MSc, Alberta, Canada, and Dr. Martin Widmann, MD, Germany, for proofreading this manuscript and their critical remarks. The authors declare that they have no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hoefert, S., Grimm, M., Sharghi, F. et al. Atraumatic tooth extraction in patients taking bisphosphonates: a review of literature and experience with three cases. Oral Maxillofac Surg 18, 341–349 (2014). https://doi.org/10.1007/s10006-014-0452-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10006-014-0452-7